Back To: Home




February 11-12, 2010
Screening Europe - Barcelona, Spain

March 4-5, 2010

More Events
Name:
Company:
Email:
 
 
 



February 2010
Novartis seeks to acquire eye giant Alcon, but is meeting resistance...
by Jeffrey Bouley

February 2010
Following Wyeth merger, multiple recent deals and job layoffs, pharma refocuses drug development pipeline...
by Amy Swinderman

February 2010
AstraZeneca acquires Novexel, expands collaboration with Forest Laboratories in effort to boost antibiotic pipeline...
by Lori Lesko

February 2010
Special R&D unit takes control of compounds discovered in other companies’ labs...
by David Hutton



Guest Commentary


 
By Dr. Gordon Sanghera
Co-founder and CEO of Oxford Nanopore Technologies

 
 
 
Above: Sanghera with a model of the protein nanopore alpha-hemolysin


February 2010
In the past decade, the role academic intuitions play in drug discovery has evolved, with more emphasis being placed on finding the chemical compounds that can modulate that promising target... [ more ]
by Dr. Michael R. Jackson

February 2010
Pfizer is continuing its fight with generic drug manufacturer United Laboratories =in the Philippines over the issue of the validity of the patent on Lipitor as Unilab tries to have the patent canceled... [ more ]
by Stephen Albainy-Jenei

February 2010
Couls we attract biotech and pharma companies to Cleveland, where the median home price is about $106,000, and opportunities to work with some of the country’s most highly regarded hospital and educational institutions — the Cleveland Clinic and Case Western Reserve University (CWRU), to name two — abound?.. [ more ]
by Amy Swinderman





SABiosciences


Beckman Genomics

Invitrogen

Caliper Life Sciences

R&D Systems
CONTACT US
Drug Discovery News
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2009 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.